Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel


BioStem Technologies Signs Letter of Intent to Acquire Exclusive US Distribution Rights for revyve™ from ProgenaCare Global BioStem Technologies Signs Letter of Intent to Acquire Exclusive US Distribution Rights for revyve™ from ProgenaCare Global

View post:
Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

Related Posts